688513 logo

Chengdu Easton Biopharmaceuticals Co., Ltd. Stock Price

SHSE:688513 Community·CN¥7.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

688513 Share Price Performance

CN¥43.96
0.38 (0.87%)
CN¥43.96
0.38 (0.87%)
Price CN¥43.96

688513 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with proven track record.

2 Risks
2 Rewards

Chengdu Easton Biopharmaceuticals Co., Ltd. Key Details

CN¥1.4b

Revenue

CN¥346.1m

Cost of Revenue

CN¥1.0b

Gross Profit

CN¥731.6m

Other Expenses

CN¥274.3m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 21, 2026
1.57
74.40%
20.29%
2.6%
View Full Analysis

About 688513

Founded
2009
Employees
1480
CEO
Mingxu Yuan
WebsiteView website
www.eastonpharma.cn

Chengdu Easton Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of pharmaceutical products in China and internationally. The company offers active pharmaceutical ingredients; finished dosage forms, including capsules, tablets, and injections; pharmaceutical intermediates; biological drugs; and generic drugs. Its products are used in oncology, cardiovascular, neurology and psychiatry, anesthetic and analgesics, urinary, anti-inflammatory, anti-diabetes, anthelmintic, and antiemetic therapeutic categories. The company was founded in 2009 and is headquartered in Chengdu, China.

Recent 688513 News & Updates

Recent updates

No updates